FDA Warning Letter — Shilpa Medicare Limited
The FDA took a Warning Letter action against Shilpa Medicare Limited on October 9, 2020 (Jadcherla, Mahabubnagar District, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Shilpa Medicare Limited
- Date
- October 9, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Center
- CDER
- Location
- Jadcherla, Mahabubnagar District (India)